ARHS News and Press, Arhaus Inc. From 04/05/22

Arhaus (ARHS -3.2%) stock edged lower after Guggenheim Securities cut its price target to $12 from $15, citing recent moderation in growth retail multiples, and reiterated its Buy rating. The new PT implies 33.6% upside to ARHS' last close. Analyst Steven Forbes believes ARHS shares...

Normally, you would expect CEOs in the same industry to agree on the facts even if they have different opinions about how those facts would affect their company. It isn't often that two CEOs have completely different takes on what is happening in the economy. That's exactly what happene...

Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....

Arhaus, Inc. (ARHS) Q4 2021 Earnings Conference Call March 30, 2022, 8:30 AM ET Company Participants John Reed – Co-Founder, Chairman, and Chief Executive Officer Wendy Watson – Senior Vice President of Investor Relations Dawn Phillipson – Chief Financial Officer Jennifer...

Shares of Arhaus (NASDAQ: ARHS) charged sharply higher on Wednesday, surging as much as 27.5%. As of 10:49 a.m. ET, the stock was still up 22.9%. The catalysts that sent the purveyor of high-end furniture higher were quarterly earnings results that were far better than expec...

Arhaus press release (NASDAQ:ARHS): Q4 GAAP EPS of $0.07 beats by $0.21. Revenue of $238.23M (+46.3% Y/Y) beats by $26.77M. 1Q22 guidance: : Net revenue in the range of $232 million to $236 million vs consensus $208.76M, net income in the range of $12 million to $14 million, with an...

BOSTON HEIGHTS, Ohio, March 30, 2022 (GLOBE NEWSWIRE) -- Arhaus, Inc. (NASDAQ: ARHS; “Arhaus” or the “Company”), a rapidly growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, reported financial results for the fourth qua...

Gainers: Sera Prognostics (SERA) +10%. Harte-Hanks  (HHS) +7%. Precigen (PGEN) +5%. Greenidge Generation Holdings  (GREE) +5%. IGM Biosciences (IGMS) +5%. Losers: Connect Biopharma Holdings Limited (CNTB) -17%. Arhaus (ARHS) -5%. Fluent (FLNT) -5%. Marinus Pharmaceuticals ...

BOSTON HEIGHTS, Ohio, March 16, 2022 (GLOBE NEWSWIRE) -- Arhaus (NASDAQ: ARHS), a rapidly growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, will release its fourth quarter and full year 2021 financial results before market open on Wednesday, Marc...

Arhaus is not a bad play in the furnishings market by any means. The company's operating history is fine and recent growth is encouraging. But all factors seem to point to this likely being fairly valued at this time, even though the future for the business will probably be fine. ...